Geneyx Completes Financing To Expand Access To Its Best-In-Class Genomic Analysis Platform

Geneyx Genomex Ltd (Geneyx), an Israel-based developer of a genetic data analysis and interpretation platform, announced today that it has closed its seed round financing led by Capri Ventures and Accenture Ventures to help the company expand its global footprint and accelerate the development of its technology. Geneyx AI-based technology builds on the gold standard in global knowledge bases for interrogating genetic information and leverages AI to improve risk prediction, diagnostic yield, prognostic prediction, and treatment insights supporting clinical decision-making and biopharmaceutical research, helping to accelerate the development of targeted and personalized therapeutics. By providing biomedical interpretation capabilities that better position clinicians and researchers to use the power of whole-genome sequencing, Geneyx is advancing human health.